Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral G100 in Cutaneous T Cell Lymphoma
NCT03742804Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of G100 in cutaneous T-cell lymphoma (CTCL), sponsored by Yale University. Planned start Jun 2019; status: withdrawn.
02
Drugs
G100
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT03742804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742804.